Download presentation
Presentation is loading. Please wait.
1
Atrial Fibrillation, AntiCoagulation
Mahesh Pauriah Consultant Cardiologist & Cardiac Electro- physiologist
2
Case 1 74 year old lady Routine visit
Irregularly irregular pulse on examination Mild SOB on moderate exertion PMH: Hypertension Meds: valsartan Allergies Nil Examination: HR 115 bpm , BP 135/76 mmHg Heart sounds normal – chest clear
5
Bloods: 2 weeks ago FBC: Hb 12.5 mg/dl, Normal Renal function TFTs Normal What would you do? – patient feels well
6
Rate control Ant coagulate
7
Rate control : beta blocker – Bisoprolol 2
Rate control : beta blocker – Bisoprolol 2.5 mg BD , calcium channel blocker if asthma +/-Digoxin Bisoprolol 2.5 mg BD , increase to 3.75 mg BD, then 5 mg DB- then change to once a day meds Aim for a resting HR < 90 bpm
8
Anticoagulate : CHADSVasc Score
Warfarin Xorelto , Dabigatran, Apixiban ? DC Cardioversion
9
Dental Issues Endoscopy / Colonoscopy Surgery PCI- antiplatelets
10
6 Months later – complains of increasing SOB,
Bilateral ankle oedema Orthopnoea/ PND ECG: Rate control AF ECHO – severe LV Impairment.
11
Heart Failure Meds- ACE inhibitor Diuretics Spironolactone. Optimise meds
12
GI Bleeding
13
Atrial Fibrillation AF is very common More common in men than women.
AF rates in the population increases with increasing age. lifetime risk of atrial fibrillation has been estimated to be 1 in 5 of the population
14
Background
15
Change with Time
16
Types of Atrial Fibrillation
(1) Paroxysmal AF is self-terminating, usually within 48 h (2) Persistent AF: defined if AF episode either lasts longer than 7 days or requires termination by cardioversion, either with drugs or by direct current cardioversion (DCC) (3) Long-standing persistent AF : if AF is present for ≥1 year
17
Natural History
18
Strategies to Treat AF ANTICOAGULATION RATE vs RHYTHM CONTROL
19
Risk of Stroke
21
Left Atrial Appendage Thrombus
22
Risk of Stroke Determine The Risk of Stroke
Risk of Bleeding with anticoagulation CHADS Score or CHADSVASC Score
24
CHADSVASC and Risk of Stroke
26
Anticoagulation Warfarin – Keep INR between 2-3 NOAC Dabigatran
Rivoraxaban Apixiban Endoxaban
27
Tachy-Brady Syndrome
29
Symptomatic or poor heart rate control/ Intolerant to Meds
30
Anticoagulation Based on ChadsVasc Score Rate Vs Rhythm Control
For asymptomatic Patients rate control as good as rhythm control Aim for resting HR < 90 bpm and < 110 bpm on exercise For symptomatic patients- try to keep sinus rhythm Trial of cardioversion for most patients
31
Rate Control Beta Blockers
Bisoprolol – start small and increase dose Digoxin – may need to dose a level 6 nours post dose Addition of Digoxin to Beta Blockers may reduce the dose of Beta Blockers required Calcium channel Blockers- eg Diltiazem/ Verapamil- use with caution- Heart Failure
32
Case Study 2 35 year old man Marathon Runner
Episodes of Irregular Irregular Heart rhythm Lasts for 4-6 hours Bloods Normal ECG Normal Echo Normal Several Holter monitor Normal
33
Modern Technology
34
ALIVECOR
37
Example of Transmission
38
Diagnosis Paroxysmal Atrial Fibrillation Treatment Medical Ablation
39
Medical Management of AF
Reassurance- this is not not going to lead to death/heart attack Refrain from Binge Drinking Relax “Ride it out” Seek help if unwell Pill in the pocket Flecainide & Beta Blockers
40
Flecainide Excellent Drug However, can lead to arrhythmia
Make sure ECG Normal ECHO Normal No Evidence of Coronary Artery Disease Danger with Atrial Flutter and Flecainide alone
41
Atrial Fibrillation Ablation
For Troublesome symptomatic AF
42
Atrial Fibrillation Ablation
44
Success Rates Success rates variable Works well with Paroxysmal AF
Redo rates Less well with Persistent Poor with Longstanding Persistent AF
45
Complications Stroke- 1:200
Use Heparin intra-procedural Groin Haematoma – requiring Intervention 1:200 Tamponade 1:200 Emergency Operation or Death 1: 1000
46
Stroke in Young Man 40 year old man PMH: Nil Meds : Nil Allergies: Nil
Admitted with Stroke Good Recovery
47
Investigations Bloods Normal , Including vasculitis Screen
MRI Confirms CVA ECG ECHO Bubble Echo Holter Monitor – Normal
48
Bubble Echo
49
What Next
51
How to Implant
52
Automatic Transmission
53
Unrelated Case 65 year old man with sudden LOC a few weeks ago
Seen in AE – discharged Seen at MPH – ECG/Echo /ETT Normal Holter Normal Loop Recorder
56
Plan: Bloods/ TFTs Anticoagulation
57
Anticoagulate Holter monitor – to ascertain rate control DC Cardioversion -3 weeks before and 4 weeks afterwards
59
Case 3 84 year old Dizzy spells Bisoprolol 10 mg OD Diltiazem
PMH: Hypertension Meds: As above
61
Admit Stop all rate limiting drugs Anticoagulation Monitor – BP stable No temporary wire HR settled mild tachycardia after 4 days. Started on Bisoprolol 1.25 mg OD- HOME no pacemaker . Well 9 months later
62
Case 4 76 year old man Previously well January – fell
Subdural Haematoma 2 weeks in CUH Treated Conservatively Asprin Stopped
63
PMHX : Hypertension Discharged 2 weeks later Change in Personality Dizzy,
64
Recurrent admissions to Hospital since then – repeat CT bleed getting better
Noted to have an irregular pulse Holter : Episodes of atrial Flutter
65
ECG
66
Discussed with Neurosurgery
Admitted to Hospital Rate controlled Bisoprolol / Digoxin – Discussed with Neurosurgery Risk of bleeding high Repeat Scan in 2 weeks CHADSVasc Score 3:
68
Atrial flutter Ablation
69
Atrial Flutter
70
Repeat CT Scan today – SDH almost resolved
Can go on a NOAC
71
Case 5 78 year old gentleman Previous Bowel cancer
Treated with surgery and radiation – 5 years ago 6 months history of SOB and palpitations
72
Examination : Gross heart failure
Treated with diuretics Rate control : Digoxin and beta blockers Ramipril 5 mg BD Spironolactone Warfarin Echo : EF of about 20% [ normal > 50%]
74
Much better rate control Discharged Home
Heart rate settled Much better rate control Discharged Home Medications on Discharge Warfarin Bisoprolol 10 mg Digoxin 125 mcg Ramipril 2.5 mg OD Spironolactone 25 mg OD
75
Medications Optimised
Warfarin Ramipril 5 mg BD Bisoprolol 10 mg Digoxin
76
3 months later NYHA 3 On Optimal Meds
Anti coagulated- Recurrent PR Bleeds LBBB and rate controlled AF
77
Treatment options for patients with chronic symptomatic systolic heart failure (NYHA functional class II–IV). Treatment options for patients with chronic symptomatic systolic heart failure (NYHA functional class II–IV). Authors/Task Force Members et al. Eur Heart J 2012;33: © The European Society of Cardiology All rights reserved. For permissions please
79
Biventricular Pacemaker
80
Amiodarone – well loaded Cardioverted EF almost normal NYHA 1
Almost back to normal . Recurrent bleeds requiring transfusion
81
Changed warfarin to Apixiban 5 mg BD
Still PR Bleed- requiring transfusion
83
Lower dose of NOAC- bleed SR for 6 months- stop all anticoagulants
Declined watchman Lower dose of NOAC- bleed SR for 6 months- stop all anticoagulants Atrial Fibrillation alarm
84
Cardiac Electrophysiology, Arrhythmia & Heart Failure
85
Drugs for Heart Failure
86
Heart Failure
87
THANK YOU
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.